Monopar Therapeutics Inc.
MNPR | NASDAQ
$94.67
-$1.05 (-1.10%)
Sep 22, 2026, 12:30 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -35.30 | -16.18 | -2.93 | -14.28 | -21.99 | -52.76 |
PEG Ratio | -0.98 | -0.12 | 0.10 | -1.04 | -0.85 | -1.17 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 3.51 | 4.57 | 4.41 | 14.94 | 10.57 | 21.37 |
P/FCF Ratio | -39.66 | -39.31 | -3.14 | -20.85 | -27.36 | -71.92 |
P/OCF Ratio | -39.66 | -39.31 | -3.14 | -20.85 | -27.36 | -71.92 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0 | n/a | n/a | 0 | n/a | n/a |
Quick Ratio | 51.35 | 11.47 | 4.17 | 4.21 | 12.98 | 14.28 |
Current Ratio | 51.35 | 11.47 | 4.17 | 4.21 | 12.98 | 14.28 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -9.95% | -28.32% | -150.37% | -104.22% | -48.06% | -40.18% |
Return on Assets | -9.75% | -25.85% | -114.39% | -79.50% | -44.36% | -37.37% |
Return on Invested Capital | -12.11% | -29.37% | -158.05% | -104.35% | -48.19% | -41.48% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove MNPR